Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.

[1]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[2]  E. Hawe,et al.  Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension , 2003, Hypertension.

[3]  M. Sabatine,et al.  Asp92Asn Polymorphism in the Myeloid IgA Fc Receptor Is Associated With Myocardial Infarction in Two Disparate Populations: CARE and WOSCOPS , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Jonathan C. Cohen.  Genetic Approaches to Coronary Heart Disease , 2006 .

[5]  A. Lupas,et al.  Predicting coiled coils from protein sequences , 1991, Science.

[6]  M. Weiner,et al.  Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. , 2000, Cytometry.

[7]  A. Henney,et al.  Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. , 1994, British heart journal.

[8]  Localization of a small genomic region associated with elevated ACE. , 2000, American journal of human genetics.

[9]  N. Hirokawa,et al.  All kinesin superfamily protein, KIF, genes in mouse and human , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[11]  S. Grundy,et al.  Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.

[12]  E. Topol,et al.  Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. , 2004, American heart journal.

[13]  Bruce S. Weir,et al.  Genetic Data Analysis: Methods for Discrete Population Genetic Data. , 1991 .

[14]  G. Lowe,et al.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. , 2000, The New England journal of medicine.

[15]  F R Rosendaal,et al.  Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin Interaction of Coagulation Defects and Cardiovascular Risk Factors : Increased , 1998 .

[16]  M. H.,et al.  LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A 2 AS AN INDEPENDENT PREDICTOR OF CORONARY HEART DISEASE , 2000 .

[17]  Ames,et al.  PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA , 2000 .

[18]  N. Samani,et al.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. , 1996, Circulation.

[19]  A. Gardemann,et al.  Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. , 1999, Blood.

[20]  S. Seiler,et al.  Cargo binding and regulatory sites in the tail of fungal conventional kinesin , 2000, Nature Cell Biology.

[21]  Thomas A Trikalinos,et al.  Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. , 2006, American journal of epidemiology.

[22]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[23]  T. Murohara,et al.  Preventive cardiology: abstractAssociation of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors , 2004 .

[24]  A. Hamsten,et al.  Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Hawe,et al.  Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study , 2001, The Lancet.

[26]  M Freedman,et al.  Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction , 2001, Circulation.

[27]  D. Arveiler,et al.  Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. , 2000, Human molecular genetics.

[28]  E. Topol,et al.  Identification of four gene variants associated with myocardial infarction. , 2005, American journal of human genetics.

[29]  I. Simpson,et al.  Independent effects of the −219 G>T and ε2/ε3/ε4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study , 2003, European Journal of Human Genetics.

[30]  I. Simpson,et al.  Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. , 2003, European journal of human genetics : EJHG.

[31]  L. Tiret,et al.  Genetic Polymorphisms and Coronary Artery Disease in the South of France , 2000, Thrombosis and Haemostasis.

[32]  D. Seog,et al.  Molecular Motor Proteins of the Kinesin Superfamily Proteins (KIFs): Structure, Cargo and Disease , 2004, Journal of Korean medical science.

[33]  M. Margaglione,et al.  The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[34]  S. Ye,et al.  Association of the lymphotoxin-α gene Thr26Asn polymorphism with severity of coronary atherosclerosis , 2005, Genes and Immunity.

[35]  Y. Ohnishi,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2003, Nature Genetics.

[36]  G. Fonarow,et al.  Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways , 2004, Circulation.

[37]  J. Rotter,et al.  Genetic markers: progress and potential for cardiovascular disease. , 2004, Circulation.

[38]  Robert C. Elston,et al.  On Fisher's Method of Combining p-Values , 1991 .

[39]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[40]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[41]  G. Fonarow,et al.  Genetic Basis of Atherosclerosis: Part II: Clinical Implications , 2004, Circulation.

[42]  J. Pankow,et al.  Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. , 2007, American journal of epidemiology.

[43]  F R Rosendaal,et al.  A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. , 1997, Blood.

[44]  C. Stefanadis,et al.  Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction. , 2006, Journal of the American College of Cardiology.